• 1
    Galmiche J-P, Letessier E & Scarpignato C. Treatment of gastro-esophageal reflux disease in adults. Br Med J 1998; 316: 17203.
  • 2
    Klinkenberg-Knol EC, Festen HPM & Meuwissen SGM. Pharmacological management of gastro-esophageal reflux disease. Drugs 1995; 49: 695710.
  • 3
    Carlsson R, Dent J & Watts R, et al. Gastro-esophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 1997; 10: 11924.
  • 4
    Lee JM & O'Morain CA. Trends in the management of gastro-esophageal reflux disease. Postgrad Med 1998; 74: 14550.
  • 5
    Heading RC. Long-term management of gastro-esophageal reflux disease. Scand J Gastroenterol 1995; 30(Suppl. 213): 2530.
  • 6
    Schindlbeck NE, Klauser AG & Berghammer G, et al. Three-year follow up of patients with gastro-esophageal reflux disease. Gut 1992; 33: 10169.
  • 7
    Dent J, Brun J & Fendrick AM, et al. on behalf of the Genval Workshop Group. An evidence-based appraisal of reflux disease management—the Genval Workshop Report. Gut 1999; 44(Suppl. 2): SISI6.
  • 8
    Andersson T, Röhss K & Hassan-Alin M, et al. Pharmacokinetics (PK) and Dose–response Relationship of Esomeprazole (E). Abstract book, CPT 2000, 15–20 July 2000, Florence, Italy. Abstract 936, p. 241.
  • 9
    Lind T, Rydberg L & Kylebäck A, et al. Esomeprazole provides improved acid control versus omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 8617.DOI: 10.1046/j.1365-2036.2000.00813.x
  • 10
    Kahrilas PJ, Falk GW & Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis: a randomized controlled trial. Aliment Pharmacol Ther 2000; 14: 124958.DOI: 10.1046/j.1365-2036.2000.00856.x
  • 11
    Richter JE, Kahrilas PJ & Hwang C, et al. Esomeprazole is superior to omeprazole for the healing of erosive esophagitis in GERD patients. Gastroenterology 2000; 118(Suppl. 2): A20A20.
  • 12
    Lind T, Havelund T & Lundell L, et al. On-demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis—a placebo-controlled randomized trial. Aliment Pharmacol Ther 1999; 13: 90714.DOI: 10.1046/j.1365-2036.1999.00564.x
  • 13
    Jones RH, Hungin APS & Phillips J, et al. Gastro-oesophageal reflux disease in primary care in Europe: clinical presentation and endoscopic findings. Eur J Gen Pract 1995; 1: 14954.
  • 14
    Venables TL, Newland RD & Patel AC, et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-esophageal reflux disease in general practice. Scand J Gastroenterol 1997; 32: 96573.
  • 15
    Wu JCY, Sung JJY & Chan FKL, et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 42732.DOI: 10.1046/j.1365-2036.2000.00714.x
  • 16
    Schenk BE, Kuipers EJ & Klinkenberg-Knol EC, et al. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol 1999; 94: 8847.
    Direct Link:
  • 17
    Holtmann G, Cain C & Malfertheiner P. Gastric Helicobacter pylori infection accelerates healing of reflux oesophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 1999; 117: 116.
  • 18
    Carlsson R, Galmiche J-P & Dent J, et al. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther 1997; 11: 47382.
  • 19
    Masclee AAM, De Best ACAM & De Graaf R, et al. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease: determination of criteria and relation to endoscopy. Scand J Gastroenterol 1990; 25: 22530.